Pegah Khosravian-Dehkordi

9PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineMolecular targetsNanoelectromechanical systemsAnimal reproduction and breeding
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
Quinic and Ferulic Acid-Loaded Chitosan Nanoparticles Attenuate Experimental Ulcerative Colitis by Modulating the IL-32/IL-33/IL-34 Axis and NF-κB Signaling.

|Oct 07, 2025
Impact of nano-selenium supplementation add-on sertraline on depressive symptoms and oxidative stress in patients with major depressive disorder: a triple-blind randomized controlled trial.

Morvarid Noormohammadi, Farnaz Etesam, Ali Amini

|Aug 12, 2025
Impact of Nano-Selenium supplementation on the JAK/STAT signaling pathway in major depressive disorder: a Triple-Blind, randomized controlled trial.

Morvarid Noormohammadi, Farnaz Etesam, Ali Amini

|Jun 16, 2025
Folic Acid Targeted Selenium-Curcumin Nanoparticles to Enhance Apoptosis in Breast Cancer Cells.

Fateme Davarani Asl, Pooria Mohammadi Arvejeh, Mehdi Rezaee

|Apr 01, 2025
A novel approach for the co-delivery of 5-fluorouracil and everolimus for breast cancer combination therapy: stimuli-responsive chitosan hydrogel embedded with mesoporous silica nanoparticles.

Pooria Mohammadi Arvejeh, Fatemeh Amini Chermahini, Francesco Marincola

|Oct 17, 2024
Improved Therapeutic Efficacy: Liposome-Coated Mesoporous Silica Nanoparticles Delivering Thymoquinone to MCF-7 Cells.

Pooria M Arvejeh, Fatemeh A Chermahini, Amin Soltani

Pageof 2

Frequent Collaborators

2 joint publications

Moosa Javdani

2 joint publications

Abolfazl Barzegar

2 joint publications

Morteza Mohammadzadeh

2 joint publications

Ali Amini